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Exercise Prescription in Patients  
With Arrhythmias
Franco Giada, MD1, Pietro Delise, MD2, Alessandro Biffi, MD3,  
Silvia Priori, MD4, Massimo Santini, MDe, Antonio Raviele, MD5
Epidemiological, clinical and laboratory studies have yielded definitive evidence 
that physical activity is able to reduce the morbidity and mortality of cardiovascular 
diseases and to improve physical fitness and quality of life. Moreover, physical activ-
ity seems to be capable of significantly reducing the risk of developing other chronic 
diseases, such as obesity, osteoporosis, diabetes, some neoplasms and depression. 
For these reasons, physical exercise has been proposed as an efficacious, low-cost, 
physiological means of disease prevention and therapy. However, although enormous 
amounts of scientific data have demonstrated the benefits of a physically active lifestyle, 
only a minority of people in Europe take regular physical exercise. One of the prime 
objectives of healthcare institutions is therefore to promote physical activity in the 
general population, as well as in patients with cardiovascular diseases. 
In the present review, we analyze the following points: some clinical aspects of 
arrhythmias and their relationships with physical exercise; the specific recommenda-
tions for exercise prescription in the various arrhythmias and in arhythmogenic heart 
diseases; the interactions between physical activity and antiarrhythmic therapies. 
c L I N I c A L  A s P E c t s  O f  A r r H Y t H m I A s
D I A G N O s t I c  A N D  P r O G N O s t I c  m A N A G E m E N t  
O f  PA t I E N t s  W I t H  A r r H Y t H m I A s
Many cardiac arrhythmias are clinically well tolerated; others depress pump 
function to varying degrees, and some can lead to sudden death. Sudden death is 
normally linked to an acquired or congenital heart disease. In the arrhythmic subject 
therefore, the presence and type of any underlying heart disease should first of all 
be evaluated1-4.
During clinical history, it is important to check for the presence of a family his-
tory of sudden death or genetic heart disease, arrhythmia-related symptoms (espe-
cially syncope) and possible triggering factors (e.g. hyperthyroidism). With regard to 
instrumental investigations, 12-lead ECG is crucial; indeed, in addition to yielding 
diagnostic information on single arrhythmias, in many cases it enables most potentially 
arrhythmic heart diseases to be discovered, or at least suspected. Further investigations 
may be prescribed when an organic heart disease is suspected (echocardiography), 
when the circadian pattern and the response of individual arrhythmias to effort need 
to be assessed (Holter monitoring, exercise testing), or when the mechanism of the 
arrhythmia itself is to be analysed (electrophysiological study).
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r E L A t I O N s H I P s  b E t W E E N  A r r H Y t H m I A s  A N D 
P H Y s I c A L  E x E r c I s E
Generally, physical exercise does not induce direct 
favourable effects on arrhythmic burden of patients with 
arrhythmias. Indeed, by increasing sympathetic activity, 
physical effort tends to favour the onset of both ventricular 
and supraventricular tachycardias. Moreover, increased sym-
pathetic tone reduces the threshold of ventricular fibrillation. 
Finally, in pathological conditions, effort can induce arrhyth-
mias indirectly through mechanisms such as ischemia, left 
ventricular outflow obstruction, etc. However, because of the 
above mentioned capacity to reduce total and cardiovascular 
morbidity and mortality, and to improve physical fitness and 
quality of life, judicious physical activity must be precribed 
also in patients with arrhythmias.
In the absence of heart disease, most arrhythmias are 
well tolerated from the haemodynamic point of view, even 
during effort. In the presence of heart disease, however, and 
obviously in relation to the type and degree of the disease, 
many arrhythmias can compromise pump function and even 
cause cardiac arrest.
Some heart diseases are particularly vulnerable to the 
development of malignant ventricular arrhythmias during 
effort: hypertrophic cardiomyopathy, arrhythmogenic right 
ventricular cardiomyopathy, coronary heart disease (including 
congenital coronary anomalies) and myocarditis. Some ion 
channel disorders (long-QT syndrome, catecholaminergic 
polymorphic ventricular tachycardia) can be added to these. 
Some physical activities may arouse a strong emotional re-
sponse (e.g. downhill skiing, climbing, etc); these are therefore 
to be avoided in all those arrhythmogenic conditions that 
are favoured by a sudden increase in catecholamines (e.g. 
long-QT syndrome). Finally, in sinus bradycardias and nodal 
atrio-ventricular blocks, regular high-intensity aerobic activity 
may have a worsening effect. 
In those arrhythmias and potentially arrhythmogenic 
syndromes that are associated with a risk of syncope, any 
physical activity in which loss of consciousness may lead to 
death by injury or drowning (“intrinsic risk” activities), such 
as climbing, motorcycle sports, swimming, sub-water diving, 
etc., must be avoided. 
r E c O m m E N D A t I O N s  
I N  t H E  v A r I O U s  A r r H Y t H m I A s  
A N D  I N  A r r H Y t H m O G E N I c  D I s E A s E s
The specific recommendations in the various arrhythmias 
and in potentially arrhythmogenic genetic heart diseases are 
summarized in table 1 and 2.
I N t E r r A c t I O N s  b E t W E E N  E x E r c I s E 
A N D  A N t I A r r H Y t H m I c  t H E r A P I E s
A N t I A r r H Y t H m Ic PH A r m AcOL OGIcA L t H E r A P Y
Many subjects with arrhythmias take anti-arrhythmic 
drugs, most of which can have both cardiac and extra-cardiac 
side-effects. In prescribing physical activity, it should be born 
in mind that some drugs tend to depress myocardial contractil-
ity to varying degrees (e.g. class IC); while their effect is not 
significant in non-cardiopathic subjects, it may be considerable 
in patients with depressed left ventricular pump function. 
Moreover, other drugs reduce cardiac output, thereby reducing 
the chronotropic response to effort (e.g. beta-blockers), and 
others are banned by the International Olympic Committee 
as doping agents (e.g. beta-blockers, diuretics). 
t r A N s c A t H E t E r  A b L A t I O N
Transcatheter alation is widely used in clinical practice to 
treat tachyarrhythmias. This procedure creates one or more 
coagulative lesions in the myocardium which tend to heal 
within a few days. There is no evidence to suggest that ablation 
has major arrhythmogenic effects. The treated arrhythmia may 
recur if the lesion is insufficient and its efficacy only transitory, 
though in general this will come to light within a few hours or 
a few days. After an efficacious ablation procedure, patients 
can undertake physical activity compatible with their state of 
health within a fairly short time (one month), as long as they 
suffer no symptomatic or electrocardiographic (e.g. reappear-
ance of the delta wave in WPW] recurrence. In asymptomatic 
subjects, follow-up electrophysiological study is not normally 
necessary, with the exception of particular cases.
Patients who undergo ablation for atrial fibrillation (pul-
monary vein isolation, etc] or for atrial flutter, often suffer 
early recurrences, which may be asymptomatic. Moreover, 
many of these patients have to remain on anticoagulant 
therapy for long periods. An adequate observation period is 
therefore necessary before any type of physical exercise can 
be prescribed. 
PA c E m A K E r s  ( P m ]
Patients who have a PM may or may not be affected by 
structural heart diseases and by various arrhythmias. The type 
of physical activity that can be undertaken will depend on these 
differing circumstances1-4. The following recommendations 
apply to these patients: 
 a.  In the first 6 months after implantation, the patient should 
avoid vigorous exercise and extreme movements of the 
ipsilateral limb, in order to avoid lead dislodgement;
 b.  Activities involving physical contact or high intrinsic risk, 
and those performed in high-pressure environments e.g. 
sub-water diving], are to be avoided, as these may damage 
the stimulator and/or the pacing leads. These precautions 
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tAbLE 2. Recommendations for exercise prescription in arrhythmogenic genetic diseases
syndrome Evaluations 
recommended
clinical situations recommendations
Long-QT syndrome (QTc 
>450 ms in males and  
>470 ms in females)
Holter, Echo, ET a) asymptomatic, carrier of the 
genetic defect with negative 
phenotype
b) symptomatic
a) mild intensity activities; avoid sudden 
effort and activities with intrinsic risk. 
Consider ICD for high-risk subjects 
(QTc >600 ms, etc)
b) mild intensity activities
Short-QT syndrome  
(QTc <320 ms) 
Holter, Echo, ET a) asymptomatic, no family history 
of sudden death
b) family history of sudden death, 
symptomatic
a) mild intensity activities. Consider ICD 
for carriers of the genetic defect and 
in the positive phenotype
b) No activity; consider ICD 
Brugada’s syndrome Holter, Echo, ET; 
consider EPS
a) asymptomatic, low-risk 
b) asymptomatic, high-risk 
c) symptomatic
a) mild intensity activities 
b) mild intensity activities; consider ICD
c) Consider ICD
Arrhythmogenic right 
ventricle cardiomyopathy 
Holter, Echo, ET a) asymptomatic without 
arrhythmias
b) asymptomatic with non-
repetitive arrhythmias 
c) symptomatic
a) mild-moderate intensity activities 
b) mild intensity activities; avoid aerobic 
activities 
c) Consider ICD
Catecholaminergic 
ventricular tachycardia
Holter, Echo, ET In all cases Mild intensity activities
Consider ICD
Hypertrophic 
cardiomyopathy
Holter, Echo, ET a) asymptomatic, low-risk
b) symptomatic and/or high-risk
a) mild intensity activities
b) mild intensity activities; consider ICD
are particularly important if the patient is PM-depend-
ent;
 c.  Correct adjustment of the heart rate during effort should 
be assessed (by means of exercise testing and/or Holter 
monitoring). In this regard, it should be pointed out that, 
in sinus node disease, heart rate adjustment during effort 
is enabled by the AAI-R and DDD-R stimulation modes; 
in complete AVB, by the DDD and VDD modes; and in 
chronic atrial fibrillation, by the VVI-R mode. Given the 
different features of the sensors utilized in rate-responsive 
PM, evaluation must be made on a case-by-case basis; 
 d.  Since right ventricular stimulation can, in time, worsen 
left ventricular pump function and/or accentuate mitral 
regurgitation, these parameters should be checked periodi-
cally. 
I m P L A N t A b L E  D E f I b r I L L A t O r  ( I c D ]
A patient with an ICD may have a structurally normal 
heart or be affected by organic diseases that do not sig-
nificantly compromise left ventricular pump function. Many 
patients, especially if young, should not be precluded from an 
active life, or even from sport, simply because they have an 
ICD. Moreover, even patients with structural heart disease 
can benefit from physical exercise1-4. 
In ICD patients, in addition to the recommendations ap-
plicable to PM patients, the following considerations should 
be made: 
 a.  patients who have already suffered from ventricular tachy-
cardias or ventricular fibrillation should not undertake 
demanding physical activity for at least six months after 
the last appropriate ICD intervention; 
 b.  it should be borne in mind that sinus tachycardia may cause 
inappropriate shocks, as the ICD may interpret the sinus 
tachycardia as a ventricular tachycardia if it exceeds the 
programmed cut-off rate. To obviate this risk, the ICD 
should be a dual-chamber model (which discriminates 
better between the two situations); the discrimination 
algorithms should be active; the programmed cut-off rate 
should be high (if possible, above the patient’s maximum 
heart rate); and the use of beta-blockers should be con-
sidered. In addition, patients should be made aware of 
the problem so that they can check their own heart rate 
during effort. Given the wide variability among individual 
patients, evaluation (by means of exercise testing and/or 
EXERCISE PRESCRIPTION IN PATIENTS WITH ARRHYTHMIAS
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Holter monitoring) should be made on a case-by-case 
basis; 
 c.  in spite of the protection provided by the ICD, activities 
that can trigger malignant arrhythmias are to be avoided.
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